What are the risks and consequences of continuing lorazepam (Ativan) 1 mg nightly in a 58‑year‑old man who has been using it for 15 years?

Continued Lorazepam Use in a 58-Year-Old: Serious Risks After 15 Years

After 15 years of nightly lorazepam use, this 58-year-old man faces substantial risks including cognitive impairment, falls, physical dependence with severe withdrawal potential, and possibly increased mortality—the drug should be gradually tapered and discontinued. 1, 2

Critical Risks of Long-Term Benzodiazepine Use in This Age Group

Cognitive and Functional Impairment

• Benzodiazepines cause cognitive impairment, reduced mobility, unsafe driving skills, and decline of functional independence in older adults, even in those approaching age 60. 1
• Elderly long-term lorazepam users demonstrate significantly poorer memory recall and slowed psychomotor performance following each dose, with these adverse effects persisting despite chronic use. 3
• Lorazepam can cause drug-induced pseudodementia that may be misdiagnosed as true dementia, along with oversedation, amnestic disorders, confusion, depression, and ataxia. 4
• The drug is capable of causing significant impairment to driving and psychomotor abilities independent of blood concentration. 5

Falls and Fractures

• Benzodiazepines are associated with increased risk of falls and fractures in older patients, a particularly concerning outcome given the patient's age. 1
• The American Geriatrics Society identifies high-potency, long-acting, or prolonged use of benzodiazepines as high risk according to Beers Criteria. 1

Physical Dependence and Withdrawal Dangers

• The FDA warns that continued benzodiazepine use for several days to weeks leads to clinically significant physical dependence, with risks increasing with longer treatment duration. 2
• After 15 years of use, abrupt discontinuation can precipitate acute withdrawal reactions that can be life-threatening, including seizures. 2
• Withdrawal symptoms include severe rebound insomnia (sleep disturbance several times worse than baseline), rebound anxiety exceeding pre-treatment levels, and potential for delirium. 6, 7

Addiction and Abuse Potential

• Benzodiazepines expose users to risks of abuse, misuse, and addiction, which can lead to overdose or death, particularly with concomitant use of other CNS depressants. 2

Possible Mortality Risk

• Emerging evidence suggests long-term lorazepam prescription may be independently associated with worse overall survival in certain patient populations, though this requires further validation. 8

Current Guideline Recommendations

Duration of Use

• Current consensus guidelines advise use of benzodiazepines solely on a short-term basis, not for 15 years of continuous nightly use. 1
• The American Geriatrics Society strongly recommends avoiding medications that induce delirium, specifically listing benzodiazepines among inappropriate medications for older adults. 1

Age-Specific Concerns

• At 58 years old, this patient is approaching the age threshold where benzodiazepine risks become particularly pronounced—guidelines specifically warn about use in patients approaching and beyond age 60. 1
• Older patients are at increased risk of withdrawal adverse reactions after benzodiazepine discontinuation, especially those with longer durations of use like this patient. 2

Recommended Management Strategy

Discontinuation Approach

• A gradual taper is essential—abrupt cessation after 15 years of use could precipitate life-threatening withdrawal including seizures, delirium, and autonomic instability. 2
• The taper should be individualized and very slow given the 15-year duration of use, potentially taking months rather than weeks. 1

Alternative Treatments

• Safer alternatives should be pursued, including antidepressants, cognitive-behavioral therapy, problem-solving therapy, interpersonal and supportive psychotherapy. 1
• Integrative strategies such as massage, aromatherapy, music therapy, and multisensory stimulation should be considered as adjunctive approaches. 1

Monitoring During Taper

• Close monitoring is required for withdrawal symptoms including anxiety, insomnia, confusion, seizures, and autonomic instability. 2
• If severe withdrawal develops, the dose should be re-escalated immediately and a slower taper resumed. 2

Common Pitfalls to Avoid

• Never abruptly discontinue after 15 years of use—this is potentially life-threatening. 2
• Do not underestimate the severity of physical dependence that has developed over this extended period. 2
• Avoid prescribing additional CNS depressants during the taper, as this increases risk of respiratory depression and oversedation. 2
• Do not assume the patient is deriving meaningful benefit—studies show long-term users often have no significant therapeutic benefits while experiencing ongoing cognitive toxicity. 3